Enliven Therapeutics, Inc. Annual Return On Assets in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Enliven Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2020 to 2023.
  • Enliven Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -27.3 %, a 4.95% decline year-over-year.
  • Enliven Therapeutics, Inc. annual Return On Assets for 2023 was -25.2 %, a 51.8% increase from 2022.
  • Enliven Therapeutics, Inc. annual Return On Assets for 2022 was -52.2 %, a 97.5% decline from 2021.
  • Enliven Therapeutics, Inc. annual Return On Assets for 2021 was -26.4 %, a 34.1% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.